ANI Pharmaceuticals Inc (ANIP)
65.36
+0.41
(+0.63%)
USD |
NASDAQ |
Apr 26, 16:00
65.32
-0.04
(-0.06%)
After-Hours: 20:00
ANI Pharmaceuticals Free Cash Flow: 100.45M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | 100.45M |
| September 30, 2023 | 52.94M |
| June 30, 2023 | 19.14M |
| March 31, 2023 | -7.467M |
| December 31, 2022 | -47.66M |
| September 30, 2022 | -52.67M |
| June 30, 2022 | -52.46M |
| March 31, 2022 | -61.37M |
| December 31, 2021 | -20.32M |
| September 30, 2021 | -15.59M |
| June 30, 2021 | -17.03M |
| March 31, 2021 | 22.71M |
| December 31, 2020 | -53.06M |
| September 30, 2020 | -41.80M |
| June 30, 2020 | -14.51M |
| March 31, 2020 | -31.76M |
| December 31, 2019 | 18.08M |
| September 30, 2019 | 40.88M |
| June 30, 2019 | 27.96M |
| March 31, 2019 | 29.52M |
| December 31, 2018 | 56.16M |
| September 30, 2018 | -4.373M |
| June 30, 2018 | 3.284M |
| March 31, 2018 | -1.357M |
| December 31, 2017 | -68.57M |
| Date | Value |
|---|---|
| September 30, 2017 | -23.57M |
| June 30, 2017 | -38.18M |
| March 31, 2017 | -93.57M |
| December 31, 2016 | -121.59M |
| September 30, 2016 | -128.68M |
| June 30, 2016 | -145.21M |
| March 31, 2016 | -86.51M |
| December 31, 2015 | -15.42M |
| September 30, 2015 | -8.613M |
| June 30, 2015 | -10.45M |
| March 31, 2015 | -9.757M |
| December 31, 2014 | -13.72M |
| September 30, 2014 | -27.02M |
| June 30, 2014 | -10.31M |
| March 31, 2014 | -8.986M |
| December 31, 2013 | -5.675M |
| September 30, 2013 | -6.028M |
| June 30, 2013 | -12.21M |
| March 31, 2013 | -22.30M |
| December 31, 2012 | -25.89M |
| September 30, 2012 | -33.65M |
| June 30, 2012 | -38.48M |
| March 31, 2012 | -45.64M |
| December 31, 2011 | -48.59M |
| September 30, 2011 | -51.83M |
Free Cash Flow Range, Past 5 Years
-61.37M
Minimum
Mar 2022
100.45M
Maximum
Dec 2023
-7.027M
Average
-15.59M
Median
Sep 2021
Free Cash Flow Benchmarks
| Ligand Pharmaceuticals Inc | -4.272M |
| ADMA Biologics Inc | 3.819M |
| Dentsply Sirona Inc | 228.00M |
| Allogene Therapeutics Inc | -239.25M |
| Vanda Pharmaceuticals Inc | 12.42M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 44.74M |
| Cash from Investing (Quarterly) | -4.779M |
| Cash from Financing (Quarterly) | -11.92M |
| Free Cash Flow Per Share (Quarterly) | 2.070 |
| Free Cash Flow to Equity (Quarterly) | 40.17M |
| Free Cash Flow to Firm (Quarterly) | 46.97M |
| Free Cash Flow Yield | 8.45% |